LENSAR stock gained 2.74 percent as analysts weigh growth strategically
Published on 10/04/2026 at 18:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLENSAR stock (ISIN US52634L1089) was last at USD 6.75 on Nasdaq on October 2, 2026, up 2.74 percent from the prior close. The latest analyst signal came on October 3, 2026, when Wall Street Zen downgraded LENSAR from Buy to Hold, according to MarketBeat.
Q2 revenue grew 18 percent
LENSAR reported USD 16.5 million in total revenue for Q2 2026, an 18 percent year-over-year increase, according to The Globe and Mail. Recurring revenue reached USD 13.7 million, up 20 percent year over year and equal to 83 percent of quarterly revenue.
The operating picture also improved on the reported figures. GAAP net income was USD 3.5 million in Q2 2026, compared with a GAAP net loss of USD 1.8 million in Q2 2025, while adjusted EBITDA reached USD 3.6 million.
Recurring revenue drives the story
The company performed 58,682 procedures during Q2 2026, a 13 percent increase from the prior-year quarter. Its ALLY installed base reached 215 systems, up 30 percent year over year, and the total installed base reached 445 systems, up 9 percent.
That mix matters because recurring revenue now supplies 83 percent of quarterly sales. The same Q2 update also identified a 13-system ALLY installation backlog, giving the growth narrative a measurable commercial checkpoint, according to The Globe and Mail.
Consensus target stays above the stock
MarketBeat reported a consensus rating of Hold from three analysts, with two Buy ratings and one Sell rating. The average price target was USD 11.33, which puts the target 67.85 percent above the October 2 price of USD 6.75.
A separate September 28 initiation added a Buy rating and an USD 11.00 target from Lucid Capital Markets, as Investing.com reported. The counterweight is execution: the company said operating expenses are expected to trend higher as it increases commercial investment.
Nasdaq price and valuation
LENSAR was last at USD 6.75 on Nasdaq at 4:00 p.m. ET on October 2, 2026, with a market capitalization of USD 82.9 million and volume of 69,800 shares. The 52-week range was USD 4.95 to USD 12.94, placing the latest price below the midpoint of that range.
LENSAR stock facts
- Company: LENSAR Inc
- ISIN: US52634L1089
- Ticker: LNSR
- Trading venue: Nasdaq
- Price as of October 2, 2026, 4:00 p.m. ET: USD 6.75
- Market capitalization: USD 82.9 million (as of October 2, 2026)
- 52-week range: USD 4.95-12.94 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Equipment and Supplies
